Navigation

Announcements

Entered into a Subscription Agreement at Tanzania

Meeting with Investors/Analysts

Proceedings of Annual General Meeting

Advertisement Notice for Thyrocare’s Annual General Meeting

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Intimation under Regulation 30 and Regulation 30A in the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from
time to time (“Listing Regulations”)

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Investor call intimation

Meeting with Investors/Analysts

Newspaper Publication

Closure of Trading Window

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Announcement under Regulation 30 (LODR)-Resignation of Director

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Closure of Trading window 

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

Meeting with Investors/Analysts

EXPLORE

LINKS

REACH US

Address: D37/1, MIDC-Turbhe, Navi Mumbai

Email: investor_relations@thyrocare.com

Tel: +9122 4125 2525 / 3090 0000

CIN – L85110MH2000PLC123882

ISIN – INE594H01019

Copyright ©2025 | Thyrocare Technologies Limited. All rights reserved.

Facebook Twitter Play Linkedin Instagram
Scroll to Top